Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?

Fereidan-Esfahani, Mahboobeh; Brueck, Wolfgang; Weber, Martin S.

Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?

2015 | journal article???letter_note???. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?
Fereidan-Esfahani, M. ; Brueck, W. & Weber, M. S. (2015)
JAMA Neurology, 72(12) pp. 1407-1408. DOI: https://doi.org/10.1001/jamaneurol.2015.2869

Copy

GRO View APA Chicago MLA Vancouver